Sentieon
Mountain View · Founded 2014
About Sentieon
Sentieon develops and commercializes cloud-based bio-informatics solutions for the life sciences and clinical market. They develop and supply a suite of bioinformatics secondary analysis tools that process genomics data with high computing efficiency, fast turnaround time, accuracy, and consistency. Some of the released products include Sentieon DNAseq, a germline DNA pipeline; and Sentieon TNseq, for tumor-normal somatic variant detection. The company’s tools are scalable, deployable, upgradable, and software-only solutions. The Sentieon tools achieve their efficiency and consistency through optimized computing algorithm design and enterprise-strength software implementation. The company was founded by Jun Ye in 2014 and is headquartered in Mountain View, California.
Company Facts
- Founded: 2014
- Legal name: Sentieon, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $23.8M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2015)
- Website: sentieon.com
- Phone: (650) 282-5650
Social Profiles
Canonical: https://fsome.com/organization/sentieon-8349732 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.